In the second part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss the background, findings, and importance of the ECHELON-2 clinical trial.

In the first part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss the challenges of treating patients with T-cell lymphoma.

Dr Bussel shares insight on hot topics, highlights, and key takeaways from this year's virtual event.

Dr Percival discusses the provision of care to patients with AML during the COVID-19 pandemic.

On this episode of Blood Bytes, John Leonard, MD, and Richard Furman, MD, discuss BTK inhibitors for the treatment of CLL and lymphomas.

Mary-Elizabeth Percival, MD, outlines considerations for treating patients with hematologic malignancies during the COVID-19 pandemic.

Mehdi Hamadani, MD, discusses the impact the global pandemic has had on bone marrow and stem cell transplantation for patients with blood cancers.

Experts discuss the impact of the current pandemic on managing hematologic malignancies, focusing on what is practical and needed for care of patients who may be dealing with or at risk for COVID-19.